Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
Carolyn T. Bramante, John B. Buse, David Liebovitz, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1119-1129
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Matthew C. Woodruff, Kevin S. Bonham, Fabliha A. Anam, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 80
Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 79
Solving the puzzle of Long Covid
Ziyad Al‐Aly, Eric J. Topol
Science (2024) Vol. 383, Iss. 6685, pp. 830-832
Closed Access | Times Cited: 59
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 49
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Cardiovascular disease as part of Long COVID: a systematic review
Vasiliki Tsampasian, Maria Bäck, Marco Bernardi, et al.
European Journal of Preventive Cardiology (2024)
Open Access | Times Cited: 14
Clinical course and management of COVID-19 in the era of widespread population immunity
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 2, pp. 75-88
Closed Access | Times Cited: 33
Drug Therapies for Diabetes
Roni Weinberg Sibony, Omri Segev, Saar Dor, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17147-17147
Open Access | Times Cited: 22
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019
Carolyn T. Bramante, Kenneth B. Beckman, Tanvi Mehta, et al.
Clinical Infectious Diseases (2024) Vol. 79, Iss. 2, pp. 354-363
Closed Access | Times Cited: 13
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Gail Hayward, Ly‐Mee Yu, Paul Little, et al.
Journal of Infection (2024) Vol. 88, Iss. 4, pp. 106130-106130
Open Access | Times Cited: 11
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19
Cameron D. Owens, Camila Bonin Pinto, Sam Detwiler, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 10
Long COVID: Long-Term Impact of SARS-CoV2
Huda Makhluf, Henry Madany, Kenneth Kim
Diagnostics (2024) Vol. 14, Iss. 7, pp. 711-711
Open Access | Times Cited: 10
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Metformin: Therapeutic profile in the treatment of type 2 diabetes
Clifford J. Bailey
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 3-19
Open Access | Times Cited: 9
Prevalence and Determinants of Long-term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System
Seyyed Sina Hejazian, Alireza Vafaei Sadr, Shima Shahjouei, et al.
The American Journal of Medicine (2024)
Closed Access | Times Cited: 8
From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide
Jaleel Jerry G. Sweis, Fatima Alnaimat, Valeria Flórez Esparza, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 3, pp. 325-325
Open Access | Times Cited: 8
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review
Trevor J. Plowman, Hannah Christensen, Myia Aiges, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5190-5190
Open Access | Times Cited: 7
Treatable traits for long COVID
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 15
Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney
Verónica Miguel, C. Rey, Jessica Tituaña, et al.
Redox Biology (2023) Vol. 68, pp. 102957-102957
Open Access | Times Cited: 15
Diabetes Mellitus, Energy Metabolism, and COVID-19
Caterina Conte, Elisa Cipponeri, Michael Roden
Endocrine Reviews (2023) Vol. 45, Iss. 2, pp. 281-308
Open Access | Times Cited: 15
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis
Kunwadee Noonong, Moragot Chatatikun, Sirirat Surinkaew, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID‐19: A systematic review and meta‐analysis
Antonio E. Pontiroli, Francesco Scovenna, Valentina Carlini, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 6
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top